His scientific interests lie mostly in Fragile X syndrome, Psychiatry, FMR1, Fragile X-associated tremor/ataxia syndrome and Ataxia. His biological study spans a wide range of topics, including Psychopathology, Cognition, Neuroscience, Autism and Pediatrics. His work on Developmental disorder as part of general Autism research is often related to Metabotropic glutamate receptor 5, thus linking different fields of science.
His Psychiatry research incorporates themes from Visual analogue scale, Genetic counseling, Randomized controlled trial and Clinical psychology. As a part of the same scientific study, David R Hessl usually deals with the Clinical psychology, concentrating on Anxiety and frequently concerns with X chromosome. His study in Ataxia is interdisciplinary in nature, drawing from both Genetics, Central nervous system disease, Neurological disorder, Pathology and Neuropathology.
David R Hessl mainly focuses on Fragile X syndrome, FMR1, Psychiatry, Autism and Ataxia. David R Hessl has researched Fragile X syndrome in several fields, including Audiology, Intellectual disability, Anxiety, Internal medicine and Clinical psychology. His work deals with themes such as Neuroscience, Pediatrics and Trinucleotide repeat expansion, which intersect with FMR1.
His Psychiatry study incorporates themes from Genetic counseling, Fragile x and Proband. In general Autism, his work in Autism spectrum disorder and Developmental disorder is often linked to Metabotropic glutamate receptor 5 linking many areas of study. He studied Ataxia and Fragile X-associated tremor/ataxia syndrome that intersect with Dementia, Neurological disorder, Intention tremor and Cognitive disorder.
David R Hessl mainly investigates Fragile X syndrome, FMR1, Intellectual disability, Cognition and Clinical psychology. David R Hessl has included themes like Psychological intervention, Randomized controlled trial, Developmental psychology, Autism spectrum disorder and Pediatrics in his Fragile X syndrome study. David R Hessl combines subjects such as Wechsler Adult Intelligence Scale, Ataxia, Gene silencing and Point mutation with his study of FMR1.
His Ataxia research includes themes of Corpus callosum, Fragile X-associated tremor/ataxia syndrome and Allele. David R Hessl works mostly in the field of Intellectual disability, limiting it down to topics relating to Working memory and, in certain cases, Cognitive training and Cognitive flexibility. His Clinical psychology study combines topics from a wide range of disciplines, such as Intervention, Fragile x and Autism.
Fragile X syndrome, FMR1, Intellectual disability, DNA methylation and Genetics are his primary areas of study. His multidisciplinary approach integrates Fragile X syndrome and Mailing list in his work. His Mailing list research covers fields of interest such as Qualitative analysis, Anxiety, Daily living, Fragile x and Family impact.
His study on DNA methylation is intertwined with other disciplines of science such as Point mutation, Untranslated region, Gene silencing and Wechsler Adult Intelligence Scale. His Psychometrics research incorporates themes from Down syndrome, Mental age and NIH Toolbox. The various areas that David R Hessl examines in his Eye tracking study include Mavoglurant, Randomized controlled trial, Pupil and Audiology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Advances in the treatment of fragile x Syndrome
Randi J Hagerman;Elizabeth Berry-Kravis;Walter E. Kaufmann;Michele Y. Ono.
Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS)
C. M. Greco;Robert F Berman;Ryan Martin;Flora Tassone.
Autism profiles of males with fragile X syndrome.
Susan W. Harris;David R Hessl;Beth Goodlin-Jones;Jessica A Ferranti.
American Journal on Mental Retardation (2008)
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
Elizabeth M Berry-Kravis;David Hessl;Sarah Coffey;Crystal Hervey.
Journal of Medical Genetics (2009)
Fragile-X–Associated Tremor/Ataxia Syndrome (FXTAS) in Females with the FMR1 Premutation
Randi J Hagerman;B. R. Leavitt;F. Farzin;S. Jacquemont.
American Journal of Human Genetics (2004)
Diurnal salivary cortisol in pediatric posttraumatic stress disorder
Victor G. Carrion;Carl F. Weems;Rebecca D. Ray;Bronwyn Glaser.
Biological Psychiatry (2002)
Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.
Faraz Farzin;Hazel Perry;David R Hessl;Danuta Loesch.
Journal of Developmental and Behavioral Pediatrics (2006)
Preschool outcomes of children of depressed mothers: role of maternal behavior, contextual risk, and children's brain activity.
Geraldine Dawson;Sharon B. Ashman;Heracles Panagiotides;David R Hessl.
Child Development (2003)
Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial
Elizabeth M. Berry-Kravis;David R Hessl;Barbara Rathmell;Peter Zarevics.
Science Translational Medicine (2012)
Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization.
Lisa Cordeiro;Elizabeth Ballinger;Randi Hagerman;David Hessl.
Journal of Neurodevelopmental Disorders (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: